Labetalol Hydrochloride Injection, Solution
Product Images NDC 68083-111

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 68083-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Labetalol 01)

Chemical structure of Labetalol Hydrochloride shown as a molecular diagram highlighting its functional groups, including an amide, hydroxyl groups, and an aromatic ring. The image represents the structural formula of the active ingredient.*

FDA Label Image

Image 2 (Labetalol 02)

Label for Labetalol Hydrochloride Injection, USP 5 mg/mL (100 mg/20 mL) by Gland Pharma Limited. The label states it is for intravenous injection only, in a 20 mL multiple dose vial. It includes storage instructions, preservative information, and manufacturer details from Hyderabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.